Activx Biosciences Inc.
This article was originally published in Start Up
Executive Summary
Activx Biosciences Inc. is positioning itself as a second-generation proteomics company with what it claims is the first high-throughput chemistry platform for activity-based proteomics. The company aims to convert the massive amounts of raw genomics data into targets for drug discovery by using chemical probes to directly measure protein activity.